Lev Silberstein, M.D., Ph.D.

faculty member

Lev Silberstein, M.D., Ph.D.

Assistant Member
Clinical Research Division, Fred Hutch

Fax: 206.667.6124
Mailstop: 01-100

Dr. Lev Silberstein studies factors that regulate the behavior of normal and malignant stem cells in the bone marrow. He and his colleagues aim to develop new ways to boost blood cell production in patients with blood disorders, inherited bone marrow failure and those recovering from blood stem cell transplants.

Other Appointments & Affiliations

Attending Hematologist
Seattle Cancer Care Alliance

Assistant Professor of Medicine
University of Washington

Education

M.D., Novosibirsk Medical Institute

M.B.B.S. equivalent, King’s College School of Medicine and Dentistry, London (UK)

Ph.D., University of Cambridge (UK)

Research Interests

Micro-environmental control of hematopoietic stem/progenitor quiescence

Restoration of hematopoietic stem cell function in bone marrow failure

Development of therapeutic strategies to enhance post-transplant reconstitution

Current Projects

Characterization of novel extrinsic regulators of hematopoietic stem cell/progenitor quiescence

Pharmacological modulation of hematopoietic stem cell quiescence to restore hematopoiesis in myelodysplasia (funded by Leukemia and Lymphoma Society Translational Research Program Award)

Find A Clinical Trial

Dr. Silberstein in the News

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email media@fredhutch.org or call 206.667.2210.